mcIRBP-9
mcIRBP-9 is an orally active NF-κB inhibitor. mcIRBP-9 reduces the levels of TNF-α, IL-1β and TGF-β1 in renal tissues, and decreases LPS-induced IL-1β production. mcIRBP-9 can be used in research related to diabetic nephropathy and type 2 diabetes mellitus.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1489241-80-6
- Formule: C42H74N12O11
- Masse moléculaire:923.11
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
mcIRBP-9 (1 μmol kg?1; p.o.; single dose given after LPS challenge) suppresses LPS-induced renal NF-κB activity and systemic IL-1β production in NF-κB transgenic mice, demonstrating anti-inflammatory activity relevant to nephropathy[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:NF-κB transgenic (male, 6-week-old)[1]
-
Dosage:1 μmol kg-1
-
Administration:p.o.; single dose given after LPS challenge
-
Result:Reduced serum IL-1β levels by 69.28 % compared to LPS-only controls.
Suppressed LPS-induced renal NF-κB-dependent luminescent intensities by 61.78 % compared to LPS-only controls.
Chemical Information
-
CAS No. 1489241-80-6
-
Masse moléculaire 923.11
-
Formule C42H74N12O11
-
Sequence
Ile-Val-Ala-Arg-Pro-Pro-Thr-Ile-Gly
-
Sequence Shortening
IVARPPTIG
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)